100 Participants Needed

Affective Control Training for Emotional Instability

(N-ACT Trial)

JA
NA
JA
Overseen ByJD Allen, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, Berkeley
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Neurobehavioral Affective Control Training (N-ACT) for emotional instability?

Research shows that training emotion regulation through real-time fMRI neurofeedback can help control emotions by reducing activity in the amygdala, a brain area involved in emotion. This approach has been effective in improving emotion regulation in conditions like borderline personality disorder and depression, suggesting potential benefits for emotional instability.12345

Is Affective Control Training for Emotional Instability safe for humans?

The studies reviewed focus on neurofeedback and emotional skills training, which are generally considered safe. They involve non-invasive techniques like real-time fMRI and EEG to help regulate emotions, with no significant safety concerns reported in healthy participants.26789

How is the treatment N-ACT different from other treatments for emotional instability?

N-ACT is unique because it focuses on training the brain's emotional control by enhancing working memory in an emotional context, which is different from traditional therapies that may not specifically target these cognitive processes. This approach aims to improve emotion regulation by strengthening the brain networks involved in managing emotions.1011121314

What is the purpose of this trial?

The goal of this clinical trial is to test a new cognitive training program to improve emotion regulation in adults. The investigators' primary aim is to determine whether participating in this program addresses two key features of emotion dysregulation associated with psychiatric disorders: (1) emotion-related impulsivity and (2) rumination. The investigators will further evaluate participants' perceived acceptability and feasibility of treatment procedures. Secondarily, the investigators will examine the effects of this cognitive training intervention on psychiatric symptoms and overall functioning. The researchers will compare the cognitive training program to a waitlist control.Participants will be asked to complete eight weekly sessions (over two months) involving cognitive training exercises with a "coach", in addition to a baseline assessment before starting the intervention and post-treatment assessment. Each assessment includes a combination of in-person and remote data collection using self-report questionnaires, psychophysiology, and a neuropsychological battery. Participants will also complete one week of ecological momentary assessment before and after the intervention as well as a set of follow-up questionnaires administered remotely six weeks following their final training session. Researchers will compare participants randomly assigned to complete the intervention without delay to a control group of participants randomly assigned to a two-month waitlist before joining the intervention. Before beginning cognitive training, participants in the control condition will complete an additional pre-intervention/post-waitlist assessment, which will follow parallel procedures to the initial baseline assessment.

Research Team

JA

J.D. Allen, Ph.D.

Principal Investigator

University of California, Berkeley

SL

Sheri L. Johnson, Ph.D.

Principal Investigator

University of California, Berkeley

ÅH

Åsa Hammar, Ph.D.

Principal Investigator

University of Bergen

Eligibility Criteria

This trial is for adults with mood symptoms, emotional distress, impulsivity, and related mental health issues. Participants should be able to complete eight weekly sessions of cognitive training and various assessments. Those with severe psychiatric disorders or conditions that might interfere with the study are likely excluded.

Inclusion Criteria

Current residency in the state of California
Elevated levels of rumination and/or emotion-related impulsivity

Exclusion Criteria

Insufficient English language literacy to understand study procedures (as assessed by self-report)
Careless or inattentive responding as indicated by failing 50% or more of 'attention check' items embedded in the online screening questionnaires, overly rapid responding, or qualitative review of long strings of identical entries on screening/baseline questionnaire items that suggest data invalidity
I have had a brain tumor, neurological issues, or significant head injuries.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants complete a baseline assessment including self-report questionnaires, psychophysiology, and a neuropsychological battery

1 week
1 visit (in-person and remote)

Pre-intervention Ecological Momentary Assessment (EMA)

Participants complete one week of ecological momentary assessment before the intervention

1 week

Treatment

Participants undergo eight weekly sessions of cognitive training exercises with a coach

8 weeks
8 visits (in-person and remote)

Post-treatment Assessment

Participants complete a post-treatment assessment with comparable measures to baseline

1 week
1 visit (in-person)

Post-intervention Ecological Momentary Assessment (EMA)

Participants complete a second week of ecological momentary assessment after the intervention

1 week

Follow-up

Participants complete follow-up questionnaires administered remotely six weeks following their final training session

6 weeks

Treatment Details

Interventions

  • Neurobehavioral Affective Control Training
Trial Overview The trial tests a new program called Neurobehavioral Affective Control Training aimed at improving emotion regulation. It involves weekly sessions over two months, comparing immediate intervention participants to a waitlisted control group.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Waitlist controlExperimental Treatment1 Intervention
Participants randomly assigned to the two-month waitlist control condition will be recontacted approximately 10 weeks after the baseline in-person assessment session (Week 1) to complete a second assessment session (with comparable measures) post-waitlist, prior to starting the N-ACT program. The post-waitlist assessment session (Week 11) after the waitlist period (Weeks 2-10) will precede a series of procedures equivalent to the experimental ("N-ACT without delay") arm: One subsequent week of pre-intervention (post-waitlist) ecological momentary assessment (EMA; Week 12), then eight weeks of N-ACT (Weeks 13-20), followed by a third and final in-person (post-intervention) assessment (Week 21) with parallel procedures to the baseline and post-waitlist sessions, as well as a second week of EMA (Week 22). All study procedures are identical between the two trial arms, with the exception of an added eight-week waitlist and post-waitlist assessment for participants in the control condition.
Group II: N-ACT without delayExperimental Treatment1 Intervention
After a baseline in-person assessment session (Week 1), participants randomly assigned to the experimental condition (i.e., "N-ACT without delay") will complete one week of pre-intervention ecological momentary assessment (EMA; Week 2), then the intervention (Weeks 3-10), followed by a post-treatment in-person assessment session with comparable measures to baseline (Week 11) and a second week of (post-intervention) EMA (Week 12).

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Berkeley

Lead Sponsor

Trials
193
Recruited
716,000+

University of Bergen

Collaborator

Trials
306
Recruited
695,000+

University College, London

Collaborator

Trials
884
Recruited
38,770,000+

Findings from Research

A study using ultra-high field (7T) fMRI evaluated the reliability of brain activity related to emotion regulation across three sessions, highlighting the importance of consistent measurements for clinical biomarkers.
Key brain regions involved in emotion regulation, such as the ventrolateral and dorsolateral prefrontal cortex, demonstrated high test-retest reliability, suggesting they are strong candidates for future research on individual differences in emotion regulation and potential neurobiological markers for affective disorders.
Test-retest reliability of emotion regulation networks using fMRI at ultra-high magnetic field.Berboth, S., Windischberger, C., Kohn, N., et al.[2021]
In a study involving 15 healthy participants, training with real-time fMRI neurofeedback significantly reduced amygdala activity during emotional regulation tasks, indicating effective emotion control (p = 0.003).
Participants receiving feedback showed greater connectivity between the amygdala and brain regions involved in emotion regulation, suggesting that rt-fMRI neurofeedback could enhance learning strategies for managing emotions, with potential applications in psychotherapy.
Training emotion regulation through real-time fMRI neurofeedback of amygdala activity.Herwig, U., Lutz, J., Scherpiet, S., et al.[2019]
Affect Regulation Training (ART) significantly reduced depressive symptoms in 218 individuals with major depressive disorder compared to a waitlist control group, with a moderate effect size (d = 0.56).
Improvements in emotion regulation skills were identified as a key mechanism behind the effectiveness of ART, suggesting that enhancing these skills can be beneficial in treating depression.
Affect regulation training reduces symptom severity in depression - A randomized controlled trial.Berking, M., Eichler, E., Luhmann, M., et al.[2020]

References

Test-retest reliability of emotion regulation networks using fMRI at ultra-high magnetic field. [2021]
Training emotion regulation through real-time fMRI neurofeedback of amygdala activity. [2019]
Affect regulation training reduces symptom severity in depression - A randomized controlled trial. [2020]
Improved emotion regulation after neurofeedback: A single-arm trial in patients with borderline personality disorder. [2021]
Validation of the Nursing Diagnosis "Labile Emotional Control" in Traumatic Brain Injury. [2020]
Improvements in mindfulness, interoceptive and emotional awareness, emotion regulation, and interpersonal emotion management following completion of an online emotional skills training program. [2023]
Real-Time Functional Connectivity-Informed Neurofeedback of Amygdala-Frontal Pathways Reduces Anxiety. [2019]
Neurofeedback: A promising tool for the self-regulation of emotion networks. [2009]
Electrical fingerprint of the amygdala guides neurofeedback training for stress resilience. [2019]
10.United Statespubmed.ncbi.nlm.nih.gov
Training the emotional brain: improving affective control through emotional working memory training. [2023]
Cultivating Affective Resilience: Proof-of-Principle Evidence of Translational Benefits From a Novel Cognitive-Emotional Training Intervention. [2021]
12.United Statespubmed.ncbi.nlm.nih.gov
The mindful brain and emotion regulation in mood disorders. [2022]
Self-regulating positive emotion networks by feedback of multiple emotional brain states using real-time fMRI. [2018]
14.United Statespubmed.ncbi.nlm.nih.gov
Modulatory effects of dynamic fMRI-based neurofeedback on emotion regulation networks in adolescent females. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security